Your browser doesn't support javascript.
loading
Microbiota: a novel regulator of pain.
Defaye, Manon; Gervason, Sandie; Altier, Christophe; Berthon, Jean-Yves; Ardid, Denis; Filaire, Edith; Carvalho, Frédéric Antonio.
Afiliação
  • Defaye M; Department of Physiology and Pharmacology, Inflammation Research Network, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.
  • Gervason S; GREENTECH SA, Saint-Beauzire, France.
  • Altier C; Université Clermont Auvergne, INSERM U1107, NeuroDol, CRHN Auvergne, 28 place Henri Dunant, BP 38, 63001, Clermont-Ferrand, France.
  • Berthon JY; Department of Physiology and Pharmacology, Inflammation Research Network, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.
  • Ardid D; GREENTECH SA, Saint-Beauzire, France.
  • Filaire E; Université Clermont Auvergne, INSERM U1107, NeuroDol, CRHN Auvergne, 28 place Henri Dunant, BP 38, 63001, Clermont-Ferrand, France.
  • Carvalho FA; GREENTECH SA, Saint-Beauzire, France.
J Neural Transm (Vienna) ; 127(4): 445-465, 2020 04.
Article em En | MEDLINE | ID: mdl-31552496
ABSTRACT
Among the various regulators of the nervous system, the gut microbiota has been recently described to have the potential to modulate neuronal cells activation. While bacteria-derived products can induce aversive responses and influence pain perception, recent work suggests that "abnormal" microbiota is associated with neurological diseases such as Alzheimer's, Parkinson's disease or autism spectrum disorder (ASD). Here we review how the gut microbiota modulates afferent sensory neurons function and pain, highlighting the role of the microbiota/gut/brain axis in the control of behaviors and neurological diseases. We outline the changes in gut microbiota, known as dysbiosis, and their influence on painful gastrointestinal disorders. Furthermore, both direct host/microbiota interaction that implicates activation of "pain-sensing" neurons by metabolites, or indirect communication via immune activation is discussed. Finally, treatment options targeting the gut microbiota, including pre- or probiotics, will be proposed. Further studies on microbiota/nervous system interaction should lead to the identification of novel microbial ligands and host receptor-targeted drugs, which could ultimately improve chronic pain management and well-being.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Cistite Intersticial / Síndrome do Intestino Irritável / Dor Crônica / Dor Visceral / Nociceptividade / Disbiose / Transtorno do Espectro Autista / Microbioma Gastrointestinal / Neurônios Aferentes Tipo de estudo: Etiology_studies Idioma: En Revista: J Neural Transm (Vienna) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Cistite Intersticial / Síndrome do Intestino Irritável / Dor Crônica / Dor Visceral / Nociceptividade / Disbiose / Transtorno do Espectro Autista / Microbioma Gastrointestinal / Neurônios Aferentes Tipo de estudo: Etiology_studies Idioma: En Revista: J Neural Transm (Vienna) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá